Aug 13, 2019 in Press Releases

XPhyto Therapeutics Commences Trading On The Frankfurt Stock Exchange

Vancouver, Canada (August 13, 2019) – XPhyto Therapeutics Corp. (CSE:XPHY) (“XPhyto” or the “Company”) is pleased to announce that its common shares have commenced trading today on the Frankfurt Stock Exchange (the “FSE”) under the ticker symbol “4XT”.

“Given XPhyto’s German cannabis licence and its commitment to building import and distribution capability in the country, a Frankfurt listing was a logical choice,” noted Hugh Rogers, CEO of XPhyto. “We are excited to help facilitate the opportunity for German investors to participate in their own emerging cannabis industry. XPhyto considers itself one of the only German focused cannabis companies in the world.”

The FSE is the largest of seven stock exchanges in Germany and one of the ten largest stock exchanges in the world. There are over 1.4 million securities tradeable on the FSE including stocks, bonds, ETFs, ETCs, ETNs, funds, warrants and certificates. The FSE is regulated under German law.